Literature DB >> 9632600

Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood.

C Ahrén1, M Jertborn, A M Svennerholm.   

Abstract

An inactivated oral enterotoxigenic Escherichia coli (ETEC) vaccine against ETEC diarrhea was given to 25 adult Swedish volunteers. The vaccine consisted of formalin-killed E. coli bacteria expressing the most common colonization factor antigens (CFAs), i.e., CFA/I, -II, and -IV, and recombinantly produced cholera B subunit (CTB). Immunoglobulin A (IgA) antibody responses in intestinal lavage fluid to CTB and CFAs were determined and compared with corresponding responses in stool extracts and serum as well as with IgA antibody-secreting cell (ASC) responses in peripheral blood. Two doses of vaccine induced significant IgA responses to the different CFAs in lavage fluid in 61 to 87% of the vaccinees and in stool in 38 to 81% of them. The most frequent responses were seen against CFA/I. The magnitudes of the antibody responses against CTB and CFA/I in stool correlated significantly (CTB, P < 0.01; CFA/I, P < 0. 05) with those in intestinal lavage. Intestinal lavage responses against CFAs were best reflected by the ASC responses, with the sensitivity of the ASC assay being 80 to 85%, followed by stool (sensitivity of 50 to 88%) and serum antibody (sensitivity of 7 to 65%) analyses. CTB-specific immune responses were seen in >90% of the vaccinees in all assays.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632600      PMCID: PMC108347     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

2.  Intestinal antibody responses after immunisation with cholera B subunit.

Authors:  A M Svennerholm; D A Sack; J Holmgren; P K Bardhan
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

3.  Identification of an intestinal immune response using peripheral blood lymphocytes.

Authors:  B D Forrest
Journal:  Lancet       Date:  1988-01-16       Impact factor: 79.321

4.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

Authors:  A M Svennerholm; M Jertborn; L Gothefors; A M Karim; D A Sack; J Holmgren
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

6.  A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

Authors:  S Hopkins; J P Kraehenbuhl; F Schödel; A Potts; D Peterson; P de Grandi; D Nardelli-Haefliger
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

8.  Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life.

Authors:  A Cravioto; R E Reyes; R Ortega; G Fernández; R Hernández; D López
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

9.  Induction of compartmentalized B-cell responses in human tonsils.

Authors:  M Quiding-Järbrink; G Granström; I Nordström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli: a prospective study.

Authors:  L Gothefors; C Ahrén; B Stoll; D K Barua; F Orskov; M A Salek; A M Svennerholm
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

View more
  34 in total

1.  Circulating immunoglobulin A- and immunoglobulin G-secreting hybridoma cells in peripheral blood preferably migrate to female genital tracts. The role of sex hormones.

Authors:  Xiaolei Wang; Xudong Zhao; Kunlong Ben; Xiaomei Cao; Yuqi Wang; Hongming Zhou
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

2.  A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation.

Authors:  Jason W Sahl; Hans Steinsland; Julia C Redman; Samuel V Angiuoli; James P Nataro; Halvor Sommerfelt; David A Rasko
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.

Authors:  Robin McKenzie; A Louis Bourgeois; Fayette Engstrom; Eric Hall; H Sunny Chang; Joseph G Gomes; Jennifer L Kyle; Fred Cassels; Arthur K Turner; Roger Randall; Michael Darsley; Cynthia Lee; Philip Bedford; Janet Shimko; David A Sack
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis.

Authors:  J Kilhamn; H Brevinge; A M Svennerholm; M Jertborn
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  M Jertborn; C Ahrén; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.

Authors:  Xiaosai Ruan; David E Knudsen; Katie M Wollenberg; David A Sack; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

7.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

8.  Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.

Authors:  Z Altboum; E M Barry; G Losonsky; J E Galen; M M Levine
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.

Authors:  E R Hall; T F Wierzba; C Ahrén; M R Rao; S Bassily; W Francis; F Y Girgis; M Safwat; Y J Lee; A M Svennerholm; J D Clemens; S J Savarino
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

10.  Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.

Authors:  C Wennerås; F Qadri; P K Bardhan; R B Sack; A M Svennerholm
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.